Fenwick Helps Cancer Biotech Freenome Raise $270M
Biotechnology company Freenome said Wednesday it raised $270 million in a financing round steered by Fenwick & West LLP that the company will use to advance its cancer detection technology....To view the full article, register now.
Already a subscriber? Click here to view full article